Literature DB >> 20698844

Skin responses to topical dehydroepiandrosterone: implications in antiageing treatment?

M El-Alfy1, C Deloche, L Azzi, B A Bernard, F Bernerd, J Coutet, V Chaussade, C Martel, J Leclaire, F Labrie.   

Abstract

BACKGROUND: Although low dehydroepiandrosterone (DHEA) is suspected to have a role in skin ageing, little information is available on the mechanisms potentially involved.
OBJECTIVES: To obtain information on androgen receptor (AR) and procollagen expression in ageing skin during DHEA treatment.
METHODS: A placebo-controlled, randomized, prospective study was performed with 75 postmenopausal women aged 60-65 years. The women were treated twice daily for 13 weeks with 3·0 mL of placebo or 0·1%, 0·3%, 1% or 2% DHEA cream applied on the face, arms, back of hands, upper chest and right thigh where 2-mm biopsies were collected before and after treatment.
RESULTS: Although the overall structure of the epidermis was not significantly affected at the light microscopy level, AR expression examined by immunocytochemistry was markedly increased by DHEA treatment. In the dermis, the expression levels of procollagen 1 and 3 mRNA estimated by in situ hybridization were increased by DHEA treatment. In addition, the expression of heat shock protein (HSP) 47, a molecule believed to have chaperone-like functions potentially affecting procollagen biosynthesis, was also found by immunocytochemistry evaluation to be increased, especially at the two highest DHEA doses.
CONCLUSION: These data suggest the possibility that topical DHEA could be used as an efficient and physiological antiageing skin agent.
© 2010 The Authors. BJD © 2010 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698844     DOI: 10.1111/j.1365-2133.2010.09972.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

Review 1.  Dehydroepiandrosterone (DHEA): hypes and hopes.

Authors:  Krzysztof Rutkowski; Paweł Sowa; Joanna Rutkowska-Talipska; Anna Kuryliszyn-Moskal; Ryszard Rutkowski
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

2.  Oral dehydroepiandrosterone might prevent frequent tears in atrophic skin: A case report.

Authors:  Harry W Daniell
Journal:  JAAD Case Rep       Date:  2017-11-06

Review 3.  Dehydroepiandrosterone: a potential therapeutic agent in the treatment and rehabilitation of the traumatically injured patient.

Authors:  Conor Bentley; Jon Hazeldine; Carolyn Greig; Janet Lord; Mark Foster
Journal:  Burns Trauma       Date:  2019-08-02

Review 4.  The Roles of Sex Hormones in the Course of Atopic Dermatitis.

Authors:  Naoko Kanda; Toshihiko Hoashi; Hidehisa Saeki
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.